CHRISTINA LEWIS: Open Payments
NPI 1851682009 · INDEPENDENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,683 in 88 payments from 20 companies in 2025. Trend: 2023 $1,073 · 2024 $1,334 · 2025 $1,683
Food & beverage: $1,663Speaker / faculty: $20
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $326 |
| Novo Nordisk Inc | 12 | $251 |
| Vanda Pharmaceuticals Inc. | 9 | $191 |
| PFIZER INC. | 9 | $144 |
| Amgen Inc. | 10 | $143 |
| Lilly USA, LLC | 6 | $92 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| Astellas Pharma US Inc | 2 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
Products named: VRAYLAR, HETLIOZ, Wegovy, NURTEC ODT, MOUNJARO, UBRELVY, REXULTI, Auvelity.
Industry payments across KY — which companies pay providers there.
